Related Experiment Videos
Cryotherapy in infants with retinopathy of prematurity. A decision model for treating one or both eyes
1Department of Pediatrics, University of Rochester, School of Medicine and Dentistry, NY.
Insights
Cryotherapy for retinopathy of prematurity treatment decisions depend on disease severity and side effect risks. Treating both eyes is only advised when side effect probability is zero; otherwise, treating one eye or none may be preferred.
Area of Science:
- Ophthalmology
- Neonatal Medicine
- Decision Science
Background:
- Retinopathy of prematurity (ROP) is a leading cause of childhood blindness.
- Cryotherapy is a common treatment for ROP, but carries risks of side effects.
- Treatment decisions for ROP require balancing efficacy with potential long-term complications.
Purpose of the Study:
- To develop a formal decision model for cryotherapy in ROP.
- To analyze how disease severity, side effect probability, and outcome correlations influence treatment recommendations.
- To identify optimal treatment strategies based on varying risk factors.
Main Methods:
- A formal decision analysis model was constructed.
- The model incorporated variables such as ROP disease severity, probability of long-term side effects, and correlations between treatment outcomes and side effects.
- Simulations were run to evaluate different treatment scenarios (both eyes, worst eye only, neither eye).
Main Results:
- Treatment decisions are highly sensitive to disease severity and the probability of long-term side effects.
- Bilateral treatment is recommended only when the probability of long-term side effects is zero.
- As side effect risks increase, treatment of neither or only the worst eye becomes preferred for a wider range of disease severities.
- High correlations of side effects favor treating only the worst eye in moderate disease.
- Bilateral treatment remains recommended for high disease severity, even with high side effect probabilities.
Conclusions:
- Current cryotherapy treatment guidelines for ROP may need refinement based on individual risk profiles.
- The decision model highlights the critical need for accurate data on long-term side effects and outcome correlations.
- Further research is essential to improve the precision of treatment recommendations for ROP, aiming to minimize blindness while mitigating treatment-related risks.
Abstract:
Formal decision model analysis for cryotherapy to reduce blindness from retinopathy of prematurity shows that the decision to treat depends substantially on disease severity, the probability of long-term side effects, and correlations of treatment outcomes and side effects for individuals in whom both eyes are treated. The model indicates that both eyes should be treated regardless of disease severity only when the probability of long-term side effects is zero. As risk of long-term side effects increase, treating neither eye or only the worst eye is preferred for an increasingly large spectrum of disease. With high correlations of long-term side effects, treating the worst eye is preferred for moderate levels of disease severity. For high disease severity, treating both eyes is recommended, even when the probability of long-term side effects is high. Better-informed treatment recommendations must await new data to assess risks of long-term side effects and correlations of treatment outcomes and side effects.